All Access Articles |
- Mineralys Therapeutics Focuses on Hypertension & Kidney Diseases | 2025-02-12 | PHARMACEUTICAL
- Mineralys Therapeutics Completes Enrollment for Hypertension Trial | 2025-02-04 | PHARMACEUTICAL
- FDA Clears Mineralys Therapeutics' IND for OSA and Hypertension Trial | 2025-01-08 | PHARMACEUTICAL
- Mineralys Therapeutics' Focus on Hypertension and Kidney Diseases | 2024-11-12 | PHARMACEUTICAL